Five-year extended hormone therapy no better in breast cancer
(HealthDay)—Extending hormone therapy by five years does not provide benefit over a two-year extension among postmenopausal women with hormone receptor-positive breast cancer who had received five years of adjuvant endocrine ...
Jul 29, 2021
0
105